Samco Small Cap Fund
Direct · GrowthAI Summary
Samco Small Cap Fund has outperformed the NIFTY SmallCap 250 benchmark across all listed periods, with a 1Y CAGR of 19.43% versus the benchmark's 13.48% and a 3Y CAGR of 6.1% versus 4.3%. However, alpha has steadily compressed over longer horizons, from 6.97% at 1Y to negative alpha of -0.48% at 15Y, suggesting the outperformance is concentrated in recent periods. SIP XIRR data is not available, so a like-for-like comparison with the category averages of roughly 20-22% cannot be made.
The fund shows a low beta of 0.85 against the benchmark, with downside capture of 81.59% well below upside capture of 90.7%, indicating a favorable asymmetry that cushions falls while participating in most of the gains. Drawdown metrics are benign, with a maximum drawdown of just -0.12% that recovered in 25 days, though one drawdown event exceeding 10% has occurred. The consistent positive alpha at shorter horizons suggests reasonable risk-adjusted outperformance, though the 15Y negative alpha warrants caution on very long-term consistency.
The fund holds 70 stocks with a well-diversified top 10 accounting for only about 26.6% of NAV, led by Karur Vysya Bank at 4.65% and Affle 3i at 3.3%. Sector exposure is balanced, with the top five sectors — Capital Markets (8.3%), Banks (8.3%), Pharmaceuticals (8.1%), Auto Components (6.5%), and Industrial Products (5.8%) — showing no single sector above 10%. This diversified, financials-and-healthcare-tilted approach reduces single-stock and sector concentration risk typical of small cap funds.
Direct comparison with category peers is limited because the fund's SIP XIRR is unavailable, while category averages stand at 21.59% (1Y) and 22.67% (3Y). Against the benchmark, the fund has delivered positive alpha over 1Y, 3Y, 5Y, and 7Y windows, but alpha turns negative beyond 10Y, indicating recent-period strength rather than long-term consistency. Investors should verify the fund's own SIP returns before judging peer standing.
This fund suits investors with a high risk tolerance and a horizon of at least 5-7 years, as small cap funds are inherently volatile despite this fund's favorable capture ratios. Its low beta and strong downside capture make it relatively suitable for investors seeking small cap exposure with somewhat moderated volatility. It should be held as a satellite allocation within a diversified portfolio, ideally via SIP to smooth entry points.
- Outperformed the NIFTY SmallCap 250 benchmark across 1Y, 3Y, 5Y, and 7Y periods, with 1Y alpha of 6.97%
- Favorable capture asymmetry with downside capture of 81.59% versus upside capture of 90.7%, cushioning losses in weak markets
- Well-diversified portfolio of 70 holdings with no single stock above 4.65% and no sector above 8.3% of NAV
- Alpha has deteriorated over longer horizons, turning negative at -0.24% over 10Y and -0.48% over 15Y, raising questions about long-term consistency
- SIP XIRR data is unavailable, preventing like-for-like comparison with category averages of roughly 20-22%
Generated on 05-09-2026, 3:02 AM. Verify before investing.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
Not enough data to compute SIP returns.
Not enough data to compute rolling returns.
Compared against NIFTY SMALLCAP 250
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +6.97 | 0.85 | 90.7% | 81.6% | 19.4% | 13.5% |
| 3 Years | +1.48 | 0.85 | 90.7% | 81.6% | 6.1% | 4.3% |
| 5 Years | +0.48 | 0.85 | 90.7% | 81.6% | 3.6% | 2.6% |
| 7 Years | +0.07 | 0.85 | 90.7% | 81.6% | 2.6% | 1.8% |
| 10 Years | -0.24 | 0.85 | 90.7% | 81.6% | 1.8% | 1.3% |
| 12 Years | -0.36 | 0.85 | 90.7% | 81.6% | 1.5% | 1.1% |
| 15 Years | -0.48 | 0.85 | 90.7% | 81.6% | 1.2% | 0.8% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | Karur Vysya Bank Limited | 4.65% |
| 2 | Affle 3i Limited | 3.30% |
| 3 | JB Chemicals & Pharmaceuticals Limited | 3.22% |
| 4 | Aditya Birla Sun Life AMC Limited | 3.10% |
| 5 | Can Fin Homes Limited | 2.84% |
| 6 | Timken India Limited | 2.48% |
| 7 | Pfizer Limited | 2.46% |
| 8 | Engineers India Limited | 2.23% |
| 9 | LT Foods Limited | 2.21% |
| 10 | UTI Asset Management Company Limited | 2.15% |